Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 3 | Journal for ImmunoTherapy of Cancer

Fig. 3

From: Prolonged intralymphatic delivery of dendritic cells through implantable lymphatic ports in patients with advanced cancer

Fig. 3

Clinical course of the disease and previous treatments of Patient # 7, the remaining long-term survivor without evidence of recurrent disease. That patient with high-level of microsatellite instability had three prior resections of the repetitively recurring intraperitoneal tumor, but remains without any sign of disease recurrence >90 months following the fourth resection, which was combined with intranodal DC vaccine administration

Back to article page